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In  the  preceding  paper  (1)  evidence  was  presented  that  the  phenomenon 
whereby large populations of tubercle bacilli can be made to "disappear" from 
the tissues of mice is produced by an alteration of the bacilli to a  sterile  ~ state. 
It was further shown: that the phenomenon is a  specific one produced by the 
actions of two drugs, pyrazinamide and isoniazid; that it occurs in all or vir- 
tually all of  the  animals in  an  experimental group;  and  that  once  assumed, 
the sterile state endures for a period measurable in months. Whether the sterile 
bacilli are  morphologically altered  cannot  be  stated  from  the  available evi- 
dence.  The  only indication of  a  host  influence in  maintaining  the  microbial 
sterility is the increased incidence of microbial revival when large daily doses 
of cortisone are given in the 3rd or 4th month  after sterilization. The present 
paper is concerned with  observations that  serve to characterize more sharply 
this phenomenon  of the sterilization of tubercle bacilli in vivo. 
Materials and Methods 
Basic modd.-- 
The basic model used in these experiments has been described in the preceding report  (1) 
and in previous publications (2, 3). In its essentials, it consists of: infecting large numbers of 
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In this paper and the one that precedes, the words ster//e and sterili~ion refer only to 
the tubercle bacilli and are used in the biologic sense of "not capable of reproduction". Such 
a state may or may not be reversible. All available methods for the detection' of living microbes 
in the tissues are based on their capacity to multiply. Once this is blocked,  it obviously be- 
comes impossible to determine directly at a particular point in time whether  living microbes 
are present or have been exterminated. The wide interest today in microbial plasticity  coupled 
with our quite limited technics for direct microbial observations  are making it necessary  to 
impose such  restrictions on familiar words when  dealing with concepts like the viability or 
the nonviability of microbes. The justification for using the  word sterile in  so  restricted a 
fashion,  therefore,  is  that  only by so  doing, can we  describe  with precision what has ac- 
tually been observed and the limits of what is presently demonstrable. 
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young  mice  (male albino,  Webster  Swiss  strain,  Carworth  Farms,  New  City,  New  York) 
with 1 to 3 million human tubercle bacilli (H37Rv) (0.2 ml of 10  -1 dilution of culture in 0.1% 
bovine albumin) by the intravenous route and administering isoniazid, 0.0125% and pyra- 
zinamide, 2.0% in the daily diet. Administration of the two drugs is started in less than 20 
minutes after infection and is continued for 12 wk. The census of culturable tubercle bacilli 
in the homogenates of the lungs and spleens of periodically sacrificed sample subgroups is 
determined at the start of therapy or cortisone administration, during and at the completion 
of the period of drug administration, and at designated periods thereafter. As was previously 
reported (1), with a very few exceptions, no tubercle bacilli capable of multiplication in mice, 
guinea pigs,  or cell-free or cell-containing cultures,  were demonstrable at the point  12  wk 
after the start of drug administration or in the succeeding month. Variations of this basic 
model are set forth in the individual experiments below. 
Drug Susceptibility Tests.-- 
Colonies of tubercle bacilli isolated from animal tissues onto solid oleic acid-albumin agar 
were  subcuitured  in  Tween®-albumin medium.  After  7  days'  incubation, the culture  was 
diluted five and one half times in Tween basal medium (without albumin or glucose) at pH 
5.55 for pyrazinamide and pH 7.2 for isoniazid. An inoculum of 0.1 ml of this suspension was 
used for each tube in the test series. (This is the equivalent of from 2 X  105 to 2 X  106 cul- 
turable units per tube.) 
An autoclaved stock solution of isoniazid in distilled water, 10 mg per ml, was used. Serial 
twofold dilutions were made in Tween-albumin medium (pH 7.2)  to give a  final volume of 5 
ml per tube. If the culture to be tested was believed to be in the susceptible range, the con- 
centrations of isoniazid used ranged from 0.008 to 2.0 #g per ml, whereas if the test culture 
was believed to be resistant, isoniazid concentrations that ranged from 0.8 to 200 #g per ml 
were  employed.  One tube of Tween-albumin medium containing no drug was included in 
each test series. 
The stock solution of pyrazinamide was 5  mg per ml of albumin-glucose (4.5% bovine 
serum albumin fraction V plus 5% glucose in physiologic saline) sterilized by Seitz filtration. 
This solution was diluted in albumin-glucose, and 0.5 ml of each dilution was added to 4.5 
ml of Tween basal medium which had been adjusted to pH 5.55 with hydrochloric acid. The 
final concentrations of pyrazinamide were 500,  100, 20, and 10 #g per ml. One tube of Tween- 
albumin medium, adjusted to 5.55,  was included in each series.  A 7 day culture  of Mycobac- 
terium tuberculosis H37Rv was included as a control for each drug. 
All cultures were examined after 7 and 14 days' incubation at 37°C. The drug susceptibility 
of the culture was defined as the lowest concentration of drug in which no macroscopic growth 
could be detected after 14 days'  incubation. If  this concentration was  below 0.064  #g  for 
isoniazid or 100 #g for pyrazinamide, the  culture  was  considered  to  be susceptible to  the 
corresponding drug. 
Catalase production: A  mixture of equal proportions of 32% hydrogen peroxide and 10% 
Tween 80 was used as reagent. One drop was applied to a  colony growing on an oleic acid 
albumin agar plate. The reaction was recorded as positive if the colony and the reagent re- 
acted by bubbling. 
Niacin production: The reagents employed were: cyanogen bromide, 10% or saturated in 
water; para-aminosalicylic acid, 1% in H~O; or aniline, 4% in 95% ethanol. For performance 
of the tests, three methods were used. In the first, 0.2 mi of a 7 day (or older) liquid culture 
(Tween-albumln medium or oleic acid-albumin), were placed in the well of a  spot plate and 
0.1 ml aniline and 0.1 cyanogen bromide were added and observed up to 10 rain for yellow 
color.  A  strain giving a  negative result was retested by the para-aminosalicylic acid  tube 
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day or older culture in oleic acid-albumin liquid medium, 1 ml of aniline, and 1 mi of cyanogen 
bromide were mixed in a test tube. The third method was used for Tween-albumin medium 
cultures. Para-aminosalicylic acid was substituted  for aniline. This method was regarded as 
final, if a. 14 day Tween-alb,,min medium culture was used. A culture of M. tuborculosis H37Rv 
was the positive control for all of these methods. 
OBSERVATIONS 
Sequential Exposure to the Two Drugs 
In the standard model employed most frequently to sterilize the populations 
of tubercle bacilli in the tissues, the period of two drug exposure had been fixed 
at 12 wk. In previously reported studies  (3), it was shown that so long as the 
12 wk period of total chemotherapy were kept constant, it was possible to pro- 
duce  the phenomenon  by administration  of the  two drugs in  sequence.  The 
order  of the  sequence  was critical,  however,  and  sterilization  occurred  with 
uniformity only when it was the isoniazid that was given first. In the particular 
experiments cited, the period of prior isoniazid administration had been arbi- 
trarily set at 4 wk followed by eight wk of pyrazinamide. To define the limits 
of the necessary period of isoniazid exposure more closely, an experiment was 
conducted in which isoniazid was followed by pyrazinamide for a  total period 
of 12 wk with different groups of animals receiving the isoniazid for 4 days, 2 
wk, and 4 wk respectively. Drug administration was started immediately after, 
i.e.  within  20  rain  of infection.  In  agreement with  the  previous studies  (3), 
complete sterilization of the tubercle bacilli was attained in the mice that had 
received the isoniazid for 4 wk. However, in the animals that had received the 
isoniazid for the lesser periods, culturable tubercle bacilli were present in 1 of 
the 7 mice in each of the two sample groups. Thus, for successful sterilization 
by the  12 wk regimen of chemotherapy, the necessary period of isoniazid in- 
fluence is more than 2, but no more than 4, wk. 
Prolongation of Two Drug Exposure to 26 Wk 
In the preceding paper (1)  it was noted that as late as 3 months after the 
cessation  of  drug  administration,  the  ultimate  destiny  of  the  sterile  bacilli 
seemed not yet decided in that, while capable of reviving, they did not always 
do so. This suggested that prolongation of the total period of drug exposure 
might exert an influence on microbial revival. Accordingly, three experiments 
were  conducted  in  which  administration  of both  drugs  was continued  for a 
total period of 26 (in one case, 25)  wk. 
Except for the duration of drug exposure, the procedures followed were essentially the 
same as in the  standard  model previously described (1). Drug administration was started 
within 20 rain of infection, which was established by the intravenous route. The inoculum 
contained one to three million tubercle bacilli. The H37Rv (Cornell) strain of tubercle bacilli 
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In all three experiments, there was complete sterilization of the populations 
of tubercle bacilli in the animal samples sacrificed at the completion of the 25 
or 26 wk period of drug exposure. No microbial revival at all was observed in 
a  6 month follow-up period in the first experiment in which no evocation by 
cortisone was attempted. There was also no microbial revival at all in the sec- 
ond experiment in which cortisone (daily dose 1.0 mg) was administered for 4 
wk to different groups of animals in the 1st and 3rd posttreatment months. In 
the third experiment, however, highly unusual mycobacteria, possibly altered 
tubercle bacilli  (see below) were isolated from the spleens of 3 animals,  2 of 
which had received cortisone, in the 3rd posttreatment month. No culturable 
tubercle bacilli were found in a  total of 28 mice sacrificed 14 or 18 wk after 
completion of therapy or from 32  other animals that had received cortisone 
during  the  4th  posttreatment  month.  The  characteristics  of  these  unusual 
mycobacteria, seen only in the posttreatment period, are presented in a  sub- 
sequent section of this paper. 
Microscopy at End of Drug Exposures.--At  the completion of the 25  (or 26) 
wk of exposure, the splenic homogenates of 5  animals from two of the above 
experiments were examined microscopically, using either the Ziehl-Nielsen or 
the  fluorescence procedure.  Microbial  forms,  morphologically  like  tubercle 
bacilli, similar to those described in the preceding paper  (1)  were present in 
sufficient numbers to permit easy detection. Crude estimates of the number of 
microbial forms present yielded values essentially the same as after the 12 wk 
regimen of drug therapy, i.e. the residual population would represent less than 
1% of the census of culturable tubercle bacilli in  the spleen 24 hr after the 
initiation of infection. 
Isoniazid Alone after 6 Wk.--A variation of the 26 wk regimen of chemotherapy was studied 
without change in either the size of the infecting inoeulum or the immediate start in the ad- 
ministration of the two drugs. The single variation was that the pyrazinamide portion of the 
two drug therapy was discontinued after 6 wk and for the remainder of the 26 wk period the 
animals received isoniazid alone. 
At the completion of the 26 wk of chemotherapy, no tubercle bacilli were 
cultured from the lungs or spleens of the 10 animals sacrificed. At the end of 
the 3rd posttreatment month,  culturable tubercle bacilli were present in the 
spleens of 10 of 14 animals. This high incidence  of microbial revival is in con- 
trast to the absence of any microbial revival in the first 3 posttreatment months 
of the 3 experiments in which the 26 wk regimen included both drugs for the 
entire period. 
In  other subgroups in  this experiment it was  observed  in  agreement with 
previous experience (3) that sterilization of the populations cannot be induced 
by a 6 wk period of administration of both drugs;  the spleens of 7 of 10 animals 
revealed culturable bacilli at that time. After the first 12  wk, however, during 
the latter half of which  only isoniazid was  administered,  there were no cul- ROBERT  ~[.  MCCUNE, FLOYD  M.  FELDMANN~  WALSH  M~CDERMOTT  473 
turable bacilli in the spleens or lungs  of the 10 animals sacrificed. No observa- 
tions on the course of microbial revival were made on this subgroup. 
Prolongation  of Infection before Drug Exposure 
Prolongation of the period of drug exposure to 26 wk represents a  variable 
that  could  be  introduced  without  variation  in  the  size  of  the  pretreatment 
population or its age in vivo. However, the next variable studied, prolongation 
of the age of the pretreatment infection, obviously carries with it other vari- 
ables that are difficult to isolate. Prominent  among  these are a  considerably 
higher census of tubercle bacilli at the time of first drug exposure and the pres- 
ence of clearly visible inflammatory-necrotic lesions. In previous studies (3) it 
had been shown that the 12 wk two drug regimen produced sterilization when 
microscopic lesions were present as a result of allowing the infection to progress 
for 21  days before the drug administration was started. 
Accordingly, experiments were conducted in which the infection was allowed 
to progress for a  considerably longer period before the start of the exposure to 
the two drugs. 
8 Wk Infe~tion.--Forty male albino mice of the Webster Swiss strain were infected intra- 
venously with 0.2 ml of a  10  -1 dilution of a 7 day culture of M. tuberculosis H37Rv and were 
allowed to remain untreated for an 8 wk period. The administration of pyrazinamide and 
isoniazid in the standard dosage was then started and continued daily for a 12 wk period. 
Nature of the Lesion.--8 wk after infection, at the time drug admln~stration was started, 
the mice appeared ill as evidenced by sluggish activity, and unkempt coats. On macroscopic 
examination post-mortem, the spleens were increased in size and a moderate number of 1 to 
2 mm lesions were scattered over all lobes of the lungs. On microscopic examination of the 
lung sections, the tissue appeared edematous and presented changes that were more extensive 
but of the same sort as were seen in the 21 day lesions (3). The cellular involvement was less 
diffuse in the 8 wk lesions; instead there were nodular accumulations of cells. In these nodules, 
many lymphocytes were mixed with histiocytes. The macrophages had foamy cytoplasm and 
contained many tubercle bacilli.  Some of the macrophages  contained what appeared to be 
ghosts of the previous site of cyrstals. These "clefts" had the aspect of cholesterol crystals. 
Pretreatment Census.--Immediately before the start of therapy, the pulmonic populations 
of tubercle bacilli were approximately 15 million (1.52 X  107) culturable units per milliliter 
of homogenized lung. This is in contrast to the situation when therapy was started immedi- 
ately after infection,  at which time the number of tubercle bacilli in the entire animal body 
could  have been little more than the one to three million organisms  just introduced. The 
splenic populations of the 8 wk infection were at about the same level as those determined at 
24 hr after infection in untreated animals. 
12 Wk and 26 Wk Regimens.--The 12 wk regimen of pyrazinamide-isoniazid 
resulted in complete sterilization of the populations of tubercle bacilli in  the 
spleen and lungs of all 15 animals sacrificed at the completion of drug therapy. 
3  months later, culturable tubercle bacilli were demonstrable in the tissues of 
6  of the 14 animals sacrificed. 
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uniformly throughout  the  15 mouse groups sacrificed at the  12  wk point and 
at the completion of therapy. In contrast to the 12 wk regimen, however, with 
the 26 wk regimen, microbial revival was found in only 1 of a  total of 60 ani- 
mals  examined  during  a  3  month  posttreatment  period.  This  single  revived 
strain was isolated at the end of the 2nd posttreatment  month from both the 
lungs and spleen  of an animal that had received no cortisone. The strain was 
resistant  to both  pyrazinamide  and  isoniazid  when  tested  separately  against 
each drug in vitro, and it did not produce catalase. A total of 39 of the 60 ani- 
mals received large daily doses of cortisone (1.0 mg) within the 3rd posttreat- 
ment month. 
15 Wk Infection 
In four experiments,  the  infection  was  allowed to progress untreated  for a 
15 wk period before drug administration was started. At this 15 wk observation 
point, the animals generally appeared ill and inactive. 
Nature of the Le,  sion.--In all experiments, the lungs of those sacrificed  immediately prior 
to therapy, were enlarged and almost completely filled with advanced lesions. The most strik- 
ing finding on postmortem examination was the extensive pulmonary involvement consisting 
of light grey granulomatous lesions, some of which were surrounded by areas of hemorrhage. 
There was hepatic and splenic enlargement but no gross lesions were present. On microscopic 
examination, the pulmonary disease represented an increase of the same kind of involvement 
as had been seen in the 8 wk lesion. In the 15 wk lesion, the tissue appeared more edematous 
and was moderately  hemorrhagic.  The inflammatory  cells were seen to be predominantly 
perivascular  and peribronchial.  More plasma  cells were seen than in the earlier lesions. A 
small amount of fibrous tissue was seen. A large number of macrophages with foamy cyto- 
plasm  contained  many acid-fast  bacilli. Many cholesterol "crystal ghosts"  were seen. The 
process resembled a lipoid pneumonia, but despite the extensive involvement, there were no 
gross areas of necrosis. 
Pretreatm~t Cozsus.--At the time of first drug exposure, the pulmonic populations were 
36 million, 54 million, 83 million, and 102 million culturable units of tubercle bacilli per milli- 
liter of homogenized lung respectively; the splenic populations were 7.8 million, 3.0 million, 
1.3 million, and 1.1 million per ml respectively. 
12 Wk and  26 Wk  Two Drug Regimen.rain  the  first  two  experiments,  the 
12 wk regimen of pyrazinamide  and isoniazid was employed and  there  was a 
failure to attain sterilization  with uniformity. In each experiment,  at the  end 
of the 12 wk period of two drug administration,  one-third of the sacrifice group 
(5 of 15 mice)  yielded  culturable  tubercle bacilli.  The 10 strains of persisting 
tubercle  bacilli  were present  in both  the lungs  and  the  spleen.  They showed 
no unusual growth or colonial characteristics  and all were susceptible  to each 
of the  two drugs when  tested  in vitro.  No other  posttreatment  observations 
were made. 
With the 26 wk regimen there was also a  failure to attain sterilization  with 
uniformity;  nevertheless  the  results  were  substantially  different  from  those 
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rificed at the completion of therapy revealed culturable tubercle  bacilli. The 
"culturable bacilli" in one experiment consisted of a single atypical colony of 
acid-fast bacilli present only in the splenic culture. In the other experiment, the 
surviving strain was present in greater numbers in both spleen and lung and 
it  grew  on  subculture.  It  was  resistant  to both pyrazinamide and isoniazid 
when tested against the two drugs separately in vitro. 
In the experiment in which the sterilization failure consisted solely of one 
colony of a  strain  that was  not subcultured,  the posttreatment  observation 
period was 3 months and cortisone was given to 30 animals.  Culturable bacilli 
were found in a  total of 9  of 38 animals:  5  of the 9 mice had received corti- 
sone; the other 4  animals had  not.  On  initial  culture,  these  9  isolates  were 
present  in numbers that  ranged  from 8  to  1824  culturable  units per  ml  of 
organ homogenate. They were not tested for drug-susceptibility. 
In the other experiment in which the only strain culturable at the completion 
of therapy was drug-resistant,  2 of the only 3  strains recovered in the post- 
treatment period were also drug-resistant,  but only to pyrazinamide. One of 
the 3 strains produced catalase whereas the other 2 did not. All 3 strains were 
recovered from 3 of the 15 mice sacrificed at the end of the 3rd posttreatment 
month; there were no culturable bacilli found in the group of 10 mice sacrificed 
6 months after the completion of treatment. On routine microscopic examina- 
tion of the pulmonary homogenates from 2 of these animals, however, minute 
bacillary forms that retained the acid-fast stain could be seen. The intensified 
microscopic search procedures described in the preceding paper (1)  were not 
used in this experiment. 
Sterilization Failures 
The  term  "sterilization failure"  is  used  to  identify those  experiments  in 
which  any tubercle bacilli could be cultured from any of the animal  groups 
sacrificed at the completion of the period of two drug exposure. Excluding  the 
2 experiments with  suboptimal periods of drug exposure, there were 5  (of  a 
total of 35) in which there was sterifization failure (Table I). In 4 of these  5 
experiments, drug-resistant bacilli were isolated; the strain present in the fifth 
experiment was not subcultured and was not tested. In 2 of the 5 experiments, 
the surviving strains were clearly identifiable as  tubercle bacilli; the strains in 
the other 3  experiments, not clearly identifiable as tubercle bacilli, were un- 
usual mycobacteria as described immediately below. The unusual mycobacteria 
encountered were of two varieties. 
The firs~ ~ar/ety was isolated at the completion of therapy in two consecutive experiments 
in 1961  in which the  12 wk two drug regimen was started immediately after infection. In 
each experiment, on one culture of pulmonary homogenate a large solitary colony appeared. 
Unlike the second variety, both of these 1961 strains were readily subcultured;  indeed, they 
grew rapidly at room temperature  on Petragnani medium.  They produced eatalase, but no 476  MICROBIAL  PERSISTENCE.  II 
niacin, and both strains were resistant to isoniazid concentrations higher than 200 #g per ml 
and pyrazinamide concentrations of 500 #g per ml. By contrast, all bacilli that were isolated 
during the posttreatment  period in both experiments were clearly identifiable tubercle bacilli 
wholly susceptible to pyrazinamide and isoniazid. 
If the two unusual strains, isolated at the completion of the 12 wk regimen of therapy, 
represented bizarre forms of drug-resistant tubercle bacilli, it would be expected that some 
drug-resistant  strains would have been found in the posttreatment  period. From both the 
context in which they arose and their biologic properties, it is suspected that these 2 strains 
do not represent tubercle bacilli but are so called "atypical"  mycobacteria. 
The situation favors the opposite interpretation for the second variety  of unusual myco- 
bacteria encountered. This variety was found in 1 of 15 animals sacrificed at the completion 
of the 25 wk two drug regimen for the 15 wk infection described above. This strain, a slow 
TABLE I 
Sterilization  Failures 
Characteristics of Mycobacterial  Strains Recovered at Completion  of Treatment  in Five 
Experiments 
Experiment  Age of 
No.  pretreatment 
infection 
1 and 2  <20 min 
3  <20 min 
4  15 wk 
5  15 wk 
Treat - 
ment 
period 
wk 
12 
12 
25 
26 
Characteristics 
End of treatment  Later posttreatment  period 
1 colony, atypical, resistant to 
both drugs 
Typical,  resistant  to  pyra- 
zinamide  (another  isolate 
susceptible) 
Slow growth no subculture 
Typical,  resistant  to  both 
drugs 
typical, drug susceptible 
Typical, resistant  to both 
drugs 
Not subcultured 
Typical,  resistant  to 
pyrazinamide 
grower, is believed to represent tubercle bacilli that had been altered by the 25 wk period of 
two drug exposure in vivo. 
The 2 strains of drug-resistant bacilli, clearly tubercle bacilli, that were iso- 
lated at  the completion of therapy have been described above in connection 
with the individual experiments. The 12 wk two drug regimen had been used 
in one experiment and the  26 wk regimen in the other.  In both experiments 
the finding of the drug-resistant strain in 1 of the animals at the completion of 
therapy  was  associated  with  a  high  incidence of  drug-resistance among  the 
tubercle bacilli isolated in the posttreatment period.  In the  experiment with 
the  12 wk regimen there was a  second animal that yielded tubercle bacilli at 
the  completion of  therapy  and  this  strain  was  susceptible  to  pyrazinamide 
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In sum: in 4 of the 5 experiments in which the sterilization failure requires 
explanation, mycobacteria resistant in vitro to one or both drugs were isolated 
at the completion of treatment. In the fifth experiment, the sole  strain sur- 
viving at the completion of treatment could not be subcultured and its drug 
susceptibility was not established.  Only 2 of the drug-resistant  strains were 
clearly identifiable as tubercle bacilli. It should be noted that in one of these 
experiments in which a  drug-resistant strain was present,  a  drug-susceptible 
strain was also isolated from another animal at the completion of the 12 wk of 
two drug therapy. 
Unusual Mycobacteria Isolated in the Posttreatment Period 
No unusual mycobacteria were found in the posttreatment period in any of 
the experiments with the 12 wk two drug regimen. With the 26 wk  regimen, 
however, there were 3 isolations that merit description. These 3 strains or iso- 
lates represent "failure" of a sort in that they were the only culturable bacilli 
found in a posttreatment observation period of at least 4 months in any of the 
3 experiments in which the 26 wk two drug regimen was started immediately 
after infection. 
All 3 isolates appeared to be the same: they were found in 3 of the 64 animals examined 
in the posttreatment period of one experiment; and 2 of the 3 animals yielding the strain, 
had received cortisone. In each case,  the strain appeared as a  single large colony of small 
nonchromogenic bacilli that retained the acid-fast stain. All 3  isolates formed catalase but 
failed to produce niacin or show "cord" formation. They were resistant to high concentra- 
tions of isoniazid and pyrazinamide in vitro and when subcultured on Petragnani medium, 
they grew in 1 wk at room temperature. Obviously, these mycobacteria were closely similar 
if not identical to the 2 strains, thought to be nontuberculous mycobacteria of the first variety, 
that were isolated at the completion of the 12 wk regimen in the 2 successive experiments in 
1961.  Caution seems advisable in concluding that these 3 "posttreatment" strains or isolates 
were not altered tubercle bacilli, however, in view of the long period of exposure to the two 
drugs (26 wk) experienced by the populations of tubercle bacilli in this experiment. 
Long-Term Survival of Tubercle Bacilli 
Observations made on another subgroup of an experiment presented above 
are  reported  here because  they illustrate  the  difficulty of establishing  that 
tubercle bacilli are not present during the long posttreatment periods necessary 
to study the sterilization phenomenon. The drug regimen used was the subop- 
timal one in which the pyrazinamide portion of the drug pair had been discon- 
tinued after only 6 wk. This was followed, in the subgroup in question, by the 
administration of isoniazid for a  1 yr period.  The drug  exposure had  been 
started immediately after the establishment of the infection. 
Despite the suboptimal nature of the regimen in terms of sterilization, no culturable tubercle 
bacilli were obtained in sample animal groups sacrificed at 12 or at 26 wk in the roughly 13 
month period of chemotherapy. 5 days after the completion of the 13 months of treatment 
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There were also no culturable bacilli found in a 10 animal group sacrificed at the end of the 
2nd posttreatment  month. At this point, the standard daily dosage of 1.0 mg of cortisone was 
started.  Eight animals died in the ensuing 3 wk and an additional 5 were sacrificed shortly 
thereafter. In 12 of the 13 there were no culturable bacilli; in 1 animal (death on day 22 of 
cortisone) a solitary colony of the second variety described previously, was present in a splenic 
culture and failed to grow on subculture. In an additional group of 5 animals that received 
no cortisone, no culturable bacilli were found when sacrificed 3 months after the completion 
of therapy. Thus, of a total of 21 animals examined during, or at the end of, the 3rd post- 
treatment month, the sole finding was a solitary "unusual" colony in 1 animal. 
As it is not possible to make exact predictions of the number of animals that will be avail- 
able for sampling in these year-long experiments, there are rare occasions when a few mice 
are still available at the planned end of the experiment. There were 3 such mice in the present 
experiment and it was decided to continue to observe them until death.  One animal died 6 
months after completion of therapy and another died 9.5 months after therapy. No culturable 
tubercle bacilli were found in the spleens or lungs of either animal. The 3rd mouse survived 
until 10 months posttreatment  or for approximately 2 yr after infection and the start of the 
13 months treatment. Culturable tubercle bacilli were present in a calculated census of 33,156 
per ml of homogenized spleen and 13,076 per ml of homogenized lung. The strain showed no 
unusual colonial morphology or growth characteristics. It produced both catalase and niacin. 
Isolates from both lungs and spleen were susceptible in vitro to isoniazid concentrations of 
0.032 #g per ml, and to pyrazinamide concentrations of 100/zg per ml. 
DISCUSSION 
From the observations presented above and those of the preceding  papers 
(1-3, 5), it is possible to define a number of the characteristics of  the steriliza- 
tion phenomenon. In the experimental conditions of the standard  12 wk two 
drug regimen started immediately after infection, and considering only those 
populations of tubercle bacilli that are in the spleen:  2 
Isoniazid does not sterilize the populations either when administered alone, or with 
streptomycin and/or para-aminosalicylic  acid (PAS) (1, 3). 
Pyrazinamide can completely sterilize the populations but it does so only irregu- 
larly when administered alone; with less than complete uniformity when given with 
streptomycin or PAS (1); and it sterilizes  with uniformity only when preceded or ac- 
companied by isoniazid. 
Together, the two drugs do not produce the phenomenon with uniformity  when the 
infecting  population of tubercle bacilli is predominantly  resistant in vitro to either one. 
Nor  does  either drug administered alone, produce it,  when the population is pre- 
dominantly  resistant to the other drug (3, 5). 
In sequence, the two drugs produce the phenomenon only when it is the isoniazid 
that is administered first, and when this period of isoniazid exposure is more than 2 wk 
but it need not be more than 4 (3, 1). Pyrazinamide thus sterilizes isoniazid-influenced 
tubercle bacilli, most of which are presumably not multiplying  at the time. 
Administered  together,  pyrazinamide blocks  the  population-reducing effects  of 
isoniazid for 2 to 3 wk.  This blocking  is produced  even when the  infecting strain is re- 
sistant  to  pyrazinamide  in  vitro  (5)  and  can  also  be  produced  by  the  pyrazina- 
mide parent drug, nicotinamide (3). 
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Tubercle bacilli in the sterile  state are nevertheless susceptible to further drug in- 
fluence; extension of the two drug exposure from 12 to 26 wk virtually abolishes micro- 
bial revival in the 4 to 6 month posttreatment period. 
A relationship exists between the size (or age) of the pretreatment population and 
the necessary period of two drug exposure. With the standard inoculum,  6 wk of two 
drug exposure are insufficient  but 12 wk are enough.  With the much larger pretreat- 
ment populations of the 15 wk infection,  12 wk of two drug exposure are insui~cient 
but 26 wk produce markedly different results. 
The relatively few sterilization failures despite presumably adequate drug exposure, 
have been associated with microbial strains resistant in vitro to pyrazinamide, or to 
both drugs? None of these relatively rare failures has been associated with resistance to 
isoniazid alone. 
Neither the host resistance acquired as a consequence of infection (1) nor the pres- 
ence of macroscopic lesions per se, appears to exert an important influence on the oc- 
currence of the sterilization.  By contrast, some host factor that can be neutralized by 
near lethal doses of cortisone appears to play some role in the postponement of micro- 
bial revival (1). 
These observations are interpreted as showing: that it is the pyrazinamide 
that possesses the sterilizing type of action; that this action can be exerted on 
populations that are undergoing little, if any, multiplication; that the range of 
this action can be broadened by concurrent administration of other antituber- 
culous drugs; but that this broadening of the action of pyrazinamide cannot be 
carried to  the point  of uniform sterilization without  an action by isoniazid; 
and  that  this essential isoniazid action does not  take place as readily in  the 
presence  or  immediately after pyrazinamide  (or  nicotinamide)  as  when  the 
isoniazid is allowed to act on the tubercle bacilli first. 
If the uniformity of the sterilization depended principally on one drug acting 
on individual tubercle bacilli not affected by the other, it would be expected: 
that isoniazid with streptomycin and PAS  would produce it;  and that when 
produced  by pyrazinamide and isoniazid,  the order  of their  sequence  should 
not be crucial. Neither of these assumptions proved to be the case. The order 
of sequence is crucial and the prior exposure to isoniazid must be longer than 
2  wk. The phenomenon  thus appears to represent a  dependent  action of the 
two drugs. 
The  capacity of  tubercle  bacilli  to  assume  this  chemically-induced  sterile 
state depends primarily on factors intrinsic  to the microbe. Once the state is 
induced, the host plays some role in inhibiting microbial revival but its role is 
not crucial (1). The rare sterilization failures, i.e. the failure to induce sterili- 
zation  with  uniformity  throughout  a  group  of  animals,  likewise  appear  to 
3 In this connection, the  true  identity  of the atypical mycobaeteria is lmimportant be- 
cause, except for the one strain not tested, they were all either resistant to pyrazinamide or 
resistant to both drugs. Thus, these unusual strains represent either incidental findings that 
can  be wholly disregarded or altered tubercle bacilli with the same pattern of drug resistance 
as the identifiable tubercle bacilli of the sterilization failures. 480  MICROBIAL  PERSISTENCE.  II 
depend on factors that are intrinsic to the microbe and largely independent of 
the host. This centrality of the microbe is in keeping with the concept that the 
sterile state is a  separately definable form of that larger microbial adaptive 
capacity known as microbial persistence (6, 7). 
The characteristics that make the phenomenon unique are not the steriliza- 
tion per se, but the facts that: it occurs with such uniformity in populations of 
this size within the 12 wk period of drug exposure; it can be induced only in 
tubercle bacilli of human origin; and it can be produced when the bacilli are 
exposed to the two chemicals in a specific sequence. 
Other  isoniazid-containing  chemotherapies,  when  administered  for  long 
periods  (e.g.  9 months)  will result in sterile populations in a  portion of the 
animals  (8).  Pyrazinamide regimens that do not include isoniazid, will also 
do this, even within the 12 wk period. Isoniazid alone, will sterilize the popula- 
tions in the lungs (but not the spleens)  of about one-half the animals in the 
12 wk period in the standard model (2).  In all of these circumstances, with 
populations of the size  of the present experiments, there is a  massive killing 
or incapacitation of the great bulk of the population in the first 4 wk of drug 
exposure but a residuum of tubercle bacilli will persist in a drug-susceptible but 
fertile state. These residual populations will be present in all animals (except 
those that received any pyrazinamide) at the 12 wk point and will persist in 
at least a small minority throughout many months of continued administration 
of the chemotherapies. Large doses of isoniazid (100 mg/kg) will sterilize the 
populations in some mice, but not in all, in the standard  12 wk period  (4). 
Very small populations (inoculum fewer than 100 culturable units)  of either 
bovine or human tubercle bacilli can also be sterilized by the use of isoniazid 
alone (9). It is not yet known, however, whether this can be done with uniform- 
ity. Presumably, in terms of initial census,  there is a  dividing point, below 
which the residual populations would not always be present at 12 wk following 
treatment with the isoniazid-containing chemotherapies that do not include 
pyrazinamide. However, with the initial census in the standard model in the 
present experiments, a census that is actually lower than in most tuberculous 
lesions,  the residual populations are invariably present. 
Thus, it is clear that sterilization per se is something that can be produced 
in tubercle bacilli in vivo by isoniazid with or without a companion drug other 
than pyrazinamide. In some cases, the sterilization takes place in only a portion 
of a population; in others, the entire population within an animal is included; 
and in still others, the major portion of the animals in a  group are involved. 
It is not known whether these tubercle bacilli, rendered sterile irregularly and 
in some cases only after many months of chemotherapy, represent the same 
microbial state  as  the bacilli in  the populations  that  are  sterilized rapidly, 
completely, and with virtual uniformity by pyrazinamide and isoniazid. From 
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gradations in the state exist as shown by differences in the incidence and rapid- 
ity of microbial revival. It is also clear that in sterilization, as in other forms of 
drug-microbe reactions involving tubercle bacilli,  the size of the population 
and the duration and amount of drug exposure are factors that govern the 
outcome. The question of gradations in the sterile state will be considered in a 
subsequent section. 
The massive killing or  incapacitation of the  great  bulk  of  the  microbial 
population that occurs in the first 4 wk of two drug exposure does not neces- 
sarily represent a dependent action of pyraziuamide and isonlazid, because it 
can be produced by the administration of either drug alone. Presumably, during 
this phase,  some bacilli could be  rendered sterile rather  than killed by the 
isoniazid, as is known to occur with the pyraziuamide. Whether the invariable 
occurrence of the residual populations represents a direct action of the isoniazid 
is not known but their sterilization with lm~formity within the 12 wk period, 
requires an action that can be provided only by isoniazid. It is this virtually 
uniform sterilization of these residual populations that is  unique,  and  that 
appears to require a dependent action of the two drugs. 
When these observations are viewed against the prominence of pyrazinamide 
resistance in the few sterilization failures, it seems reasonable to infer that the 
key factor in the uniformity of the sterilization phenomenon is the continued 
maintenance of susceptibility to the pyrazinamide. For, a considerable portion 
of  the  irregularity of  the  sterilization produced  by pyrazinamide alone,  is 
caused by the emergence of pyrazinamide-resistant tubercle bacilli (13).  For 
example, in the unsuccessful attempts to produce sterilization at 12 wk with 
streptomycin as the companion to the pyrazinamide (1),  2  of the 3  strains 
that  survived at the completion of therapy were resistant to pyrazinamide. 
The third was not tested. 
An  attractive  explanation for  the  sterilization phenomenon,  therefore,  is 
that tubercle bacilli that have survived 4 wk of isoniazid exposure are specifi- 
cally rendered incapable of exhibiting pyrazinamide-resistance on concurrent 
or subsequent exposure to the drug. If this were the case, the sterilization fail- 
ures  (exclusive of suboptimal time-dose regimens)  would consist principally, 
if not exclusively, of those instances in which it had not been possible for the 
isoniazid to block the pyrazinamide resistance because: the bacilli were already 
resistant to pyrazinamide at the time of first isonlazid exposure; they emerged 
resistant to pyraziuamide during the early weeks of concurrent therapy while the 
isoniazid influence was temporarily neutralized; or they were resistant to isonia- 
zid at the time of first exposure to that drug. In the last named circumstances, 
some of the bacilli could be sterilized solely by the action of the pyrazinamide 
alone but  those in which  this failed to  occur,  on continued drug  exposure, 
would be at high risk of pyrazinamide resistance or, in actuality, resistance to 
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to  isoniazid  alone,  would  be  quite  unusual.  The  chances for failure due  to 
pyrazinamide resistance or two drug resistance would be somewhat increased 
in the  15 wk infection model with its greater opportunity for the few drug- 
resistant cells originally present  4 to multiply (or arise de novo) before the start 
of the 26 wk period of two drug exposure. The uniformity of the sterilization 
observed in  the  standard  model  (drug  exposure  started  within  minutes  of 
infection) would thus reflect the fact that failure would require the coincidence 
of two events:  the presence of drug-resistant  cells at  the  time of first drug 
exposure; and their successful avoidance of the  action of the drug  to which 
they were susceptible.  In the  experimental conditions of the standard model 
in which drug exposure is started immediately after infection, either one of these 
events should be rare. 
None of the eventualities set forth above is at variance with the observed 
data; and this hypothesis that there is a sublethal action of isoniazid that can 
render  the  cell incapable  of exhibiting pyrazinamide resistance  is  currently 
being studied in appropriate long term experiments. 
A major characteristic of the sterile state revealed in the present studies is 
that populations that cannot be shown to be capable of multiplication in vivo 
or  in vitro are nevertheless susceptible  to further drug influence. Microbial 
revival was  strikingly suppressed when the administration of the two drugs 
was continued for an additional 14 wk after the 12 wk point at which steril- 
ization was  demonstrable.  Indeed, when the  two drug exposure was  started 
immediately after infection, revival was suppressed completely in 2 experiments 
and its occurrence in the third is not absolutely certain. When all of these experi- 
ments with the 26 wk two drug regimen are grouped together without regard 
to the pretreatment  age of the infection, bacilli  of some sort were cultured 
during the posttreatment period from 18 of the more than 300 mice examined. 
All of these 18 isolates (except for one not tested for drug susceptibility) were 
either highly abnormal in their colonial and growth characteristics, were drug 
resistant,  or were both.  This virtually complete absence of drug  susceptible 
identifiable tubercle bacilli  in  the  posttreatment  period when  the  period of 
drug exposure had been extended by 14 wk, is in contrast to the findings in 
the posttreatment period, when the drug exposure had been stopped at 12 wk. 
In the last named circumstances, considering only the standard model, all of 
the more than 300 isolates appeared as characteristic tubercle bacilli  except 
for the 9 of the 99 strains tested thus far, that showed drug resistance (6 re- 
sistant to isoniazid; 3 to pyrazinamide). 
4  The H37Rv strain of tubercle bacilli employed  in virtually all of the experiments, shows 
some fluctuation over time but generally contains approximately 5 culturable units per million 
that are resistant in vitro to isoniazid concentrations of 0.25/~g per ml. The number of units 
resistant in vitro at pH 5.5 to pyrazinamide  concentrations  of 50 #g per ml is generally  slightly 
lower, about 3  to 4  units per million. Tubercle bacilli resistant to both drugs have not been 
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The significance of the unusual or atypical bacilli is difficult to establish. 
For, there is no method by which to distinguish convincingly between a tubercle 
bacillus that has been sufficiently "battered" by its drug exposure to lose the 
characteristics  used to identify the phenotype, and adventitious infection with 
a  strain of mycobacteria other  than  M.  tuberculosis.  On  the one hand, the 
possibilities of adventitious infection by nontuberculous mycobacteria during 
the handling of the tissues postmortem or their evocation in the living animal 
by cortisone, cannot be excluded. Moreover, resistance  in vitro  to isoniazid or 
to pyrazinamide is  common among these nontuberculous mycobacteria. On 
the other hand, it is known that tubercle  bacilli  resistant to isoniazid may 
assume several different forms, some of which may appear highly atypical (10). 
As mentioned previously, the observations  suggest that there may be signifi- 
cant gradations within the sterile state. Another indication is afforded by the 
long term experiment with the suboptimal regimen of 6 wk of two drug adminis- 
tration followed by 6.5 wk of isonia.zid alone. At the 12 wk observation point, 
sterilization  was demonstrated in the 10 animal sample.  The isoniazid alone 
was then continued for a second 14 wk period at which time (26 wk) the sample 
sacrificed  also  revealed  uniform sterilization.  In  the  posttreatment period, 
however, microbial  revival was high (10 of 14 mice).  This apparently sterile 
but readily revivable  infection was subjected to a second 6 month period of 
isoniazid alone at which time no culturable bacilli were found even after evoca- 
tion attempts with cortisone.  Finally, 2 yr after infection and almost 1 year 
after the completion  of treatment, characteristic,  wholly isoniazid-susceptible 
tubercle bacilli were isolated from the last surviving animal. 
In this experiment,  the sterilization  was uniform at 12 and after 26 wk of 
drug exposure and to that extent it yielded results identical with those obtained 
when both drugs had been continued throughout. But at this 26 wk point, the 
potential for widespread  microbial  revival was much greater with the "sub- 
optimal" regimen; indeed,  it was even greater than is usually observed  after 
the standard 12 wk two drug regimen. This suggests that, regardless of whether 
the various sterile states were all qualitatively similar, the one produced by the 
predominantly isoniazid regimen was considerably less stable. 
With the standard 12 wk model, a sterilization  phenomenon with consider- 
able stability in effect was made even more stable by an additional 14 wk period 
of two drug exposure.  Obviously,  the degree  of sterility or  "gradations" of 
the sterile  state would merely reflect  the extent of the restorative processes 
that must take place for the resumption of fertility. Using revival time, as a 
measure of the extent of microbial alteration, the alteration produced by pyra- 
zinamide and isoniazid must be extreme compared with those produced by the 
other isoniazid chemotherapies.  Indeed, in the case of the 26 wk two drug regi- 
men and the 20 rain infection, the alterations are so extreme that they may  rep- 
resent the total eradication of the populations of tubercle bacilli.Thus~ the famil- 
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again (1). Caution seems advisable in assuming the uniform eradication of the ba- 
cilli in view of their demonstrated capacity to persist in the sterile state for long 
periods and then revive. As the cortisone-evoking procedure has been unsuccess- 
ful following the 26 wk two drug regimen, the tedious procedure of very long 
term observation  for "natural revival" is being employed. The appropriate experi- 
ments have not yet been conducted to determine whether the observed striking 
influence of the second 14 wk period of  two  drug  administration represents 
direct drug action on tubercle bacilli in the sterile state,  or an indirect effect 
produced by making the environment hostile to bacilli in the incipient stages 
of revival. As reported in the previous paper (1), there is good reason to believe 
that not all potentially revivable sterilized tubercle bacilli do in fact revive, at 
least  during  the  1st  yr  after  sterilization.  Conceivably,  therefore,  tubercle 
bacilli that persist, or are artificially held, in the sterile state may eventually 
be eliminated by "natural death". In the sequential experiments of the present 
study, however, when the pyrazinamide exposure was started at the 4 wk point, 
the residual populations, while not sterile, were presumably undergoing little 
multiplication,  yet  the  influence of  the  ensuing  8  wk  of pyrazinamide was 
unequivocal. Thus, the possibility that the influence exerted by the two drug 
administration past the 12 wk point, is a direct one, is by no means far fetched. 
The nature of the lesion per se does not seem to be a  significant factor in 
preventing the sterilization of the populations of tubercle bacilli therein. The 
lesions of the 8 wk infection, although considerably less extensive, were qual- 
itatively indistinguishable from those of the  15 wk infection. With  the 8 wk 
infection, at completion of the 26 wk two drug regimen, there was complete 
sterilization of the populations in the sample group sacrificed, as occurs in the 
case in the 3 wk (3) or 20 min infections. Moreover, the microbial revival was 
strikingly suppressed. In the 15 wk infection, revival was similarly suppressed 
but complete sterilization at the completion of treatment was not attained. Yet 
the results in the  15  wk and 8 wk infections may be  closer than appears at 
first glance. For, in the "8 wk" experiment and in one of the 2 "15 wk" experi- 
ments, there was a  single mouse that harbored a  small culturable population 
of tubercle bacilli resistant to both drugs. The strain in the 8 wk experiment 
was the only isolate in the posttreatment period and represents the only instance 
in the total 12 yr experience, in which a strain of indentifiable tubercle bacilli 
resistant to both drugs,  was found at any other time than as a  sterilization 
failure at the completion of therapy. It is possible that this strain was cultur- 
able at the completion of treatment but that by chance the mouse had not been 
included in the sample sacrificed then.  Thus, in the infections of all ages the 
over-all results with the 26 wk two drug regimen were thus sufficiently close 
to provide no support for the possibility that the lesion itself, interfered signifi- 
cantly with sterilization. 
Although  the  lesion  itself  seems  to  exert no  discernible  influence  on  the 
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two drug exposure is started, does appear to exert an influence. This influence 
appears  to  operate  in  two  different ways.  The first,  mentioned  previously, 
consists of the greater likelihood that drug resistant bacilli may be present in 
sufficient numbers in the large populations of the older lesions to escape ster- 
ilization by one drug and emerge as a cause of sterilization failure. The second 
has to do with the relationship that appears to exist between the length of the 
two drug exposure and the population size when exposure is started. The limits 
of  this  apparent  relationship  have  not  been  studied  systematically  in  the 
present investigation. The sterilization failures with the two drug regimen when 
administered for only 6  wk  with  the  standard inoculum,  or for only 12 wk 
with the large population of the  15 wk infection, are thought to be cases in 
point. In each instance the result was almost completely reversed by an ap- 
proximate doubling  of the period of two drug  exposure. As  mentioned pre- 
viously, it has long been recognized that population size is important in the 
drug-microbe reactions of tubercle bacilli; indeed, this factor has to be carefulb- 
standardized  in  the  performance  of  drug-susceptibility  tests  in  vitro  (11). 
In the sterilization phenomenon of the present investigation it is likely that 
the ratio-population size/length of exposure, is a fairly crude one once a census 
of a few million tubercle bacilli is attained. An analysis of 22 experiments with 
the standard model revealed no clear correlation between the extent of microbial 
revival  and  the  unavoidable  interexperiment  differences in  the  size  of  the 
"standardized" inoculum. Whether the age of the population as well as its size 
is a significant factor cannot be stated. 
The present experiments have cast no light on the question of the morpho- 
logic state of the tubercle bacilli while in the sterile state and the relation of the 
sterilized bacilli  to the  acid-fast microbial forms visible in  the  tissues.  This 
question of the microbial states during latent and dormant infections has been 
discussed elsewhere (6, 7) and is considered in detail in a more recent report by 
Pierce-Chase, Fauve, and Dubos (12). The fact that these acid-fast forms were 
readily demonstrable at the end of therapy in those 26 wk drug regimen experi- 
ments in which there has been no revival at all, casts some doubt on the pos- 
sibility that they represent revivable tubercle bacilli. 
SUMMARy 
The capability of tubercle bacilli to assume a long continued sterile state in 
the  tissues  when exposed to pyrazinamide and isoniazid is  a  highly  specific 
drug-microbe phenomenon in which host participation is not critical. Although 
it is the pyrazinamide that possesses the sterilizing type of action, the role of 
the isoniazid is specific and essential. The isoniazid serves to convert a phenom- 
enon that occurs irregularly with pyrazinamide alone into one that occurs with 
a high degree of uniformity. The observations suggest a competition between 
isoniazid and the pyrazinamide (or its parent nicotinamide) for a  site or en- 
trance in or on the tubercle bacilli and for sterilization, the isoniazid apparently 486  B~ICROBIOL  PERSISTENCE.  II 
must  reach  the  site first.  The rare failures  to  attain  complete sterilization, 
appear to depend on the emergence of pyrazinamide-resistance which prevents 
the necessary dependent action of the two drugs.  Populations already in the 
sterile state are nevertheless subject to a  continued drug influence. Whether 
this represents a direct action on the sterile bacilli or an indirect effect produced 
by making the environment hostile to microbial revival, cannot be determined 
from the present observations. 
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